Radiosynthesis and Characterization of 11C-GSK215083 as a PET Radioligand for the 5-HT6 Receptor

Christine A Parker, Roger N Gunn, Eugenii A Rabiner, Mark Slifstein, Robert Comley, Cristian Salinas, Christopher N Johnson, Steen Jakobsen, Sylvain Houle, Marc Laruelle, Vincent J Cunningham, Laurent Martarello

Research output: Contribution to journalArticle

36 Citations (Scopus)


The development of a PET radioligand for imaging 5-hydroxytryptamine (5-HT) 6 receptors in the brain would, for the first time, enable in vivo imaging of this target along with assessment of its involvement in disease pathophysiology. In addition, such a tool would assist in the development of novel drugs targeting the 5-HT6 receptor.
Original languageEnglish
Pages (from-to)295-303
Number of pages9
JournalJournal of nuclear medicine : official publication, Society of Nuclear Medicine
Issue number2
Early online date5 Jan 2012
Publication statusPublished - 1 Feb 2012



  • PET
  • serotonin
  • 5-HT6
  • receptor
  • radioligand

Cite this